Mouse embryonic stem (ES) cell line, Etv2-Venus-KI (see reference).
Comment from the depositor
Terms and conditions
1)In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Blood 2011;118:6975-6986) designated by the DEPOSITOR is required. 2) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. 3) Needs MTA with RIKEN CDB regarding the purpose of the utilization of the cell line. 4) When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Nagai, T. et al., Nat. Biotechnol. 20: 87-90 (2002).
Remarks
approver's address
×
English
Address
RIKEN Kobe Campus 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan
Dr.RIKEN, Center for Biosystems Dynamics Research
Fax. +81-78-306-0101
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Back
Top
CELL BANK Website